Studies on CLL cells considered that NC‐1 is the most potent of the PROTACs previously presented by London's group, largely due to the fact that by not binding covalently to BTK, allowed it to bind and dissociate quickly.117. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.